Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial

John W K Chia, Eva Segelov, Yanhong Deng, Gwo Fuang Ho, Wei Wang, Shuting Han, Atul Sharma, Kefeng Ding, Gong Chen, Mark G Jeffery, Chee Kian Tham, Joong Bae Ahn, Louise Nott, Robert Zielinski, Tsu-Yi Chao, Tom van Hagen, Po-Li Wei, Fiona Day, Shaesta Mehta, Thomas Yau, Jiewen Peng, Theresa M Hayes, Yong Li, Mihir Gandhi, Estelle M J Foo, Nabilah Rahman, Peter Rothwell, Raghib Ali, John Simes, Han Chong Toh

Open source

DOI
10.1016/s2468-1253(24)00387-x
Published
2025-03
Container
The Lancet Gastroenterology & Hepatology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2468-1253-24-00387-x,
  title = {Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial},
  author = {John W K Chia and Eva Segelov and Yanhong Deng and Gwo Fuang Ho and Wei Wang and Shuting Han and Atul Sharma and Kefeng Ding and Gong Chen and Mark G Jeffery and Chee Kian Tham and Joong Bae Ahn and Louise Nott and Robert Zielinski and Tsu-Yi Chao and Tom van Hagen and Po-Li Wei and Fiona Day and Shaesta Mehta and Thomas Yau and Jiewen Peng and Theresa M Hayes and Yong Li and Mihir Gandhi and Estelle M J Foo and Nabilah Rahman and Peter Rothwell and Raghib Ali and John Simes and Han Chong Toh},
  year = {2025},
  journal = {The Lancet Gastroenterology \& Hepatology},
  doi = {10.1016/s2468-1253(24)00387-x},
  url = {https://doi.org/10.1016/s2468-1253(24)00387-x}
}

RIS

TY  - JOUR
TI  - Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial
AU  - John W K Chia
AU  - Eva Segelov
AU  - Yanhong Deng
AU  - Gwo Fuang Ho
AU  - Wei Wang
AU  - Shuting Han
AU  - Atul Sharma
AU  - Kefeng Ding
AU  - Gong Chen
AU  - Mark G Jeffery
AU  - Chee Kian Tham
AU  - Joong Bae Ahn
AU  - Louise Nott
AU  - Robert Zielinski
AU  - Tsu-Yi Chao
AU  - Tom van Hagen
AU  - Po-Li Wei
AU  - Fiona Day
AU  - Shaesta Mehta
AU  - Thomas Yau
AU  - Jiewen Peng
AU  - Theresa M Hayes
AU  - Yong Li
AU  - Mihir Gandhi
AU  - Estelle M J Foo
AU  - Nabilah Rahman
AU  - Peter Rothwell
AU  - Raghib Ali
AU  - John Simes
AU  - Han Chong Toh
PY  - 2025
JO  - The Lancet Gastroenterology & Hepatology
DO  - 10.1016/s2468-1253(24)00387-x
UR  - https://doi.org/10.1016/s2468-1253(24)00387-x
ER  - 

APA

Chia, J. W. K., Segelov, E., Deng, Y., Ho, G. F., Wang, W., Han, S., Sharma, A., Ding, K., Chen, G., Jeffery, M. G., Tham, C. K., Ahn, J. B., Nott, L., Zielinski, R., Chao, T., Hagen, T. V., Wei, P., Day, F., Mehta, S., Yau, T., Peng, J., Hayes, T. M., Li, Y., Gandhi, M., Foo, E. M. J., Rahman, N., Rothwell, P., Ali, R., Simes, J., & Toh, H. C. (2025). Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(24)00387-x

Source records